The data describes the medicines in development for selected cancer types in the U.S. as of May 2018. At this moment, 132 medicines for lung cancer were in development. Thus, lung cancer was the type of cancer with one of the biggest numbers of drugs in development.
Leukemia | 137 |
Lymphoma | 135 |
Lung cancer | 132 |
Breast cancer | 108 |
Brain cancer | 90 |
Skin cancer | 46 |